Cargando…

Clinical Protocol to Prevent Thrombogenic Effect of Liver-Derived Mesenchymal Cells for Cell-Based Therapies

The efficacy of mesenchymal stem cell infusion is currently tested in numerous clinical trials. However, therapy-induced thrombotic consequences have been reported in several patients. The aim of this study was to optimize protocols for heterologous human adult liver-derived progenitor cell (HHALPC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coppin, Louise, Najimi, Mustapha, Bodart, Julie, Rouchon, Marie-Sophie, van der Smissen, Patrick, Eeckhoudt, Stéphane, Dahlqvist, Géraldine, Castanares-Zapatero, Diego, Komuta, Mina, Brouns, Sanne L., Baaten, Constance C., Heemskerk, Johan W. M., Horman, Sandrine, Belmonte, Nathalie, Sokal, Etienne, Stéphenne, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721739/ https://www.ncbi.nlm.nih.gov/pubmed/31394759 http://dx.doi.org/10.3390/cells8080846

Ejemplares similares

Thrombogenic Risk Induced by Intravascular Mesenchymal Stem Cell Therapy: Current Status and Future Perspectives
por: Coppin, Louise, et al.
Publicado: (2019)

Bivalirudin in Combination with Heparin to Control Mesenchymal Cell Procoagulant Activity
por: Stephenne, Xavier, et al.
Publicado: (2012)

vWFpp/ADAMTS13 ratio is a useful marker of postliver transplantation thrombotic microangiopathy: A pediatric case report
por: Duquenne, Lisa, et al.
Publicado: (2019)

Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders
por: Coppin, Louise C. F., et al.
Publicado: (2020)

Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade?
por: van Dievoet, Marie-Astrid, et al.
Publicado: (2020)

Progressive Fibrosis Is Driven by Genetic Predisposition, Allo-immunity, and Inflammation in Pediatric Liver Transplant Recipients
por: Varma, S., et al.
Publicado: (2016)

α1AMP-Activated Protein Kinase Protects against Lipopolysaccharide-Induced Endothelial Barrier Disruption via Junctional Reinforcement and Activation of the p38 MAPK/HSP27 Pathway
por: Angé, Marine, et al.
Publicado: (2020)

Device Thrombogenicity Emulation: An In Silico Predictor of In Vitro and In Vivo Ventricular Assist Device Thrombogenicity
por: Chiu, Wei Che, et al.
Publicado: (2019)

Detection of Human Microchimerism following Allogeneic Cell Transplantation Using Droplet Digital PCR
por: Lombard, Catherine A., et al.
Publicado: (2019)

AMP-activated protein kinase preserves endothelial tight junctions in the coronary microcirculation during sepsis
por: Castanares-Zapatero, D, et al.
Publicado: (2012)

Platelet Membrane Receptor Proteolysis: Implications for Platelet Function
por: Wu, Jiayu, et al.
Publicado: (2021)

Human Allogeneic Liver-Derived Progenitor Cells Significantly Improve NAFLD Activity Score and Fibrosis in Late-Stage NASH Animal Model
por: Najimi, Mustapha, et al.
Publicado: (2022)

Is ABO-Incompatible Living Donor Liver Transplantation Really a Good Alternative for Pediatric Recipients?
por: de Magnée, Catherine, et al.
Publicado: (2021)

Nanomedicine for the reduction of the thrombogenicity of stent coatings
por: Karagkiozaki, Varvara C, et al.
Publicado: (2010)

Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation
por: Berezin, Alexander E., et al.
Publicado: (2022)

Tumor Genetics Are Thrombogenic: The Need for Action
por: Mahé, Isabelle, et al.
Publicado: (2023)

Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage
por: Castanares-Zapatero, Diego, et al.
Publicado: (2011)

Tomographic Findings and Thrombogenic Effects of COVID-19
por: Mourão, Rodrigo, et al.
Publicado: (2020)

Targeting thrombogenicity and inflammation in chronic HIV infection
por: O’Brien, Meagan P., et al.
Publicado: (2019)

Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices
por: Labarrere, Carlos A., et al.
Publicado: (2020)

AMP-activated protein kinase controls liposaccharide-induced hyperpermeability
por: Castanares-Zapatero, D, et al.
Publicado: (2012)

Comprehensive Screening of Cell Surface Markers Expressed by Adult-Derived Human Liver Stem/Progenitor Cells Harvested at Passage 5: Potential Implications for Engraftment
por: Dollet, Pierre-Edouard, et al.
Publicado: (2016)

Age‐dependent glycosylation of the sodium taurocholate cotransporter polypeptide: From fetal to adult human livers
por: Sargiacomo, Camillo, et al.
Publicado: (2018)

Canagliflozin protects against sepsis capillary leak syndrome by activating endothelial α1AMPK
por: Angé, Marine, et al.
Publicado: (2021)

Thrombogenic Catheter-Associated Superior Vena Cava Syndrome
por: Shaikh, Imran, et al.
Publicado: (2013)

Heparanase expression upregulates platelet adhesion activity and thrombogenicity
por: Cui, Hao, et al.
Publicado: (2016)

Response to “Tomographic Findings and Thrombogenic Effects of COVID-19”
por: Bao, Cuiping, et al.
Publicado: (2020)

Cryopreservation moderates the thrombogenicity of arterial allografts during storage
por: Hidi, László, et al.
Publicado: (2021)

Assessment of the Anti-Thrombogenic Activity of Polyurethane Starch Composites
por: Cespedes, Jhoan F., et al.
Publicado: (2022)

Toll-like Receptor 4 Modulation as a Strategy to Treat Sepsis
por: Wittebole, X., et al.
Publicado: (2010)

Passive leg cycling and electrical stimulation cannot preserve strength in sepsis
por: Laterre, Pierre-François, et al.
Publicado: (2019)

In vitro reversion of activated primary human hepatic stellate cells
por: El Taghdouini, Adil, et al.
Publicado: (2015)

Diminished Thrombogenic Responses by Deletion of the Podocalyxin Gene in Mouse Megakaryocytes
por: Pericacho, Miguel, et al.
Publicado: (2011)

Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
por: Sørensen, Benny, et al.
Publicado: (2011)

From weakly adhesive to highly thrombogenic: the shear gradient switch
por: Asaad, Yathreb, et al.
Publicado: (2020)

A Novel Large Animal Model of Thrombogenic Coronary Microembolization
por: Bikou, Olympia, et al.
Publicado: (2019)

Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity
por: Cornelissen, Anne, et al.
Publicado: (2022)

Neutrophil extracellular traps induce thrombogenicity in severe carotid stenosis
por: Zhang, Shihua, et al.
Publicado: (2021)

Temporary Rise in Blood Thrombogenicity in Patients with Acute Myocardial Infarction
por: Kosugi, Shumpei, et al.
Publicado: (2022)

Thrombotic mechanisms in low-thrombogenicity mechanical mitral valve prostheses
por: Lodge, Jeorghino, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h7m070iauuolhs8t36a3s48kf3